• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Considerations for Establishing Successful Coronavirus Disease Vaccination Programs in Africa

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2021 Jun 17;27(8).
doi: 10.3201/eid2708.203870. Online ahead of print.
Considerations for Establishing Successful Coronavirus Disease Vaccination Programs in Africa

Victor Williams, Bassey Edem, Marianne Calnan, Kennedy Otwombe, Charles Okeahalam

Abstract

The accelerated development of coronavirus disease (COVID-19) candidate vaccines is intended to achieve worldwide immunity. Ensuring COVID-19 vaccination is crucial to stemming the pandemic, reclaiming everyday life, and helping restore economies. However, challenges exist to deploying these vaccines, especially in resource-limited sub-Saharan Africa. In this article, we highlight lessons learned from previous efforts to scale up vaccine distribution and offer considerations for policymakers and key stakeholders to use for successful COVID-19 vaccination rollout in Africa. These considerations range from improving weak infrastructure for managing data and identifying adverse events after immunization to considering financing options for overcoming the logistical challenges of vaccination campaigns and generating demand for vaccine uptake. In addition, providing COVID-19 vaccination can be used to promote the adoption of universal healthcare, especially in sub-Saharan Africa countries.

Keywords: Africa; COVID-19; COVID-19 vaccines; SARS-CoV-2; coronavirus disease; disease control strategies; disease transmission; pandemics; public health logistics; respiratory infections; severe acute respiratory syndrome coronavirus 2; sub-Saharan Africa; vaccination coverage; vaccination programs; vaccinations; viruses; zoonoses.
 
Back
Top Bottom